Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PicoCELA (PCLA) Cash & Equivalents (2023 - 2025)

PicoCELA has reported Cash & Equivalents over the past 3 years, most recently at $3.6 million for Q3 2025.

  • For Q3 2025, Cash & Equivalents rose 18.55% year-over-year to $3.6 million; the TTM value through Sep 2025 reached $3.6 million, up 18.55%, while the annual FY2025 figure was $3.6 million, 18.55% up from the prior year.
  • Cash & Equivalents for Q3 2025 was $3.6 million at PicoCELA, up from $3.1 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $3.6 million in Q3 2025 and troughed at $3.0 million in Q3 2023.
  • A 3-year average of $3.2 million and a median of $3.1 million in 2024 define the central range for Cash & Equivalents.
  • Biggest five-year swings in Cash & Equivalents: rose 3.34% in 2024 and later grew 18.55% in 2025.
  • Year by year, Cash & Equivalents stood at $3.0 million in 2023, then grew by 3.34% to $3.1 million in 2024, then rose by 18.55% to $3.6 million in 2025.
  • Business Quant data shows Cash & Equivalents for PCLA at $3.6 million in Q3 2025, $3.1 million in Q3 2024, and $3.0 million in Q3 2023.